FDA Inspection 1280309 — Eurofins Biopharma Product Testing Ireland Limited
The FDA completed an inspection of Eurofins Biopharma Product Testing Ireland Limited on Jun 20, 2025 in Dungarvan. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 20, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Dungarvan (Ireland)